POS0670 PATTERN OF USE OF GLUCOCORTICOIDS IN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGICS...
POS0670 PATTERN OF USE OF GLUCOCORTICOIDS IN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGICS OR TARGETED SYNTHETIC THERAPIES IN REAL LIFE: DATA FROM BIOBADASER
About this item
Full title
Author / Creator
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Background:Glucocorticoids (GC) are frequently used as bridging therapy for rheumatoid arthritis (RA) patients starting conventional synthetic disease-modifying antirheumatic drugs (csDMARD). Both EULAR and ACR guidelines (1,2), recommend to use the lowest effective dose for the shorter duration possible, ideally less than three months. However, th...
Alternative Titles
Full title
POS0670 PATTERN OF USE OF GLUCOCORTICOIDS IN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGICS OR TARGETED SYNTHETIC THERAPIES IN REAL LIFE: DATA FROM BIOBADASER
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3068503219
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3068503219
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.4157
